Friday 6 November 2026 Export PFE’s income statement to Excel — free account

Pfizer Inc.

PFE Healthcare Drug Manufacturers General

Pfizer Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.6 billion, down 1.65% from fiscal 2024.

Revenue: −0.43%
EPS: −7.98%
Free cash flow: +20.0%
Total debt: +1.55%

Quarter to September 2026, against a year earlier

29.20 0.25 −0.85%

Follow PFE

Alert me

Market cap: $170.3B
P/E: 42.2×
Fwd P/E: 18.9×
Dividend yield: 7.18%
F-score: 6/9
Altman Z: 2.03
Beneish M: −2.52
Dividend safety: 28/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Pfizer Inc. (PFE) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Pfizer Inc. (PFE) trades at a P/B ratio of 1.9×. Over the past ten years it has ranged from 1.4× (April 2025) to 4.5× (December 2021); the current reading is higher than 25% of that period. That is below the Drug Manufacturers General industry median of 5.2× and below the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/PFE/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Pfizer Inc. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/PFE/metrics/pb-ratio">Pfizer Inc. (PFE) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	1.6×	(3.96%)
FY2024	1.7×	(9.63%)
FY2023	1.9×	(37.31%)
FY2022	3.0×	(29.81%)
FY2021	4.3×	32.54%
FY2020	3.2×	(4.20%)
FY2019	3.4×	(14.45%)
FY2018	3.9×	32.42%
FY2017	3.0×	(9.60%)
FY2016	3.3×	12.79%

Period	P/B ratio	Change
Sep 2026	1.8×	13.41%
Jun 2026	1.6×	(9.19%)
Mar 2026	1.8×	8.40%
Dec 2025	1.6×	4.81%
43 more quarters	Free account

Against its own ten years

Low 1.4× High 4.5×

Ten-year median 3.0×

Current reading's percentile 28

Company	P/B ratio
SNY Sanofi compare	1.4×
PFE Pfizer Inc.	1.9×
GSK GSK PLC Sponsored ADR compare	4.1×
NVO Novo Nordisk A/S compare	5.2×
BMY Bristol Myers Squibb Company compare	5.5×
AZN AstraZeneca PLC compare	5.6×
NVS Novartis AG compare	8.2×
GILD Gilead Sciences, Inc. compare	16.1×
AMGN Amgen Inc. compare	21.4×
Drug Manufacturers General industry median	5.2×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Pfizer Inc. (PFE) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on PFE

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on PFE

Stockrow Weekly